AAnti-Hepatocellular and anti-lung Carcinoma Effect of the Selenium Nanoparticles Myco-Synthesized by Penicillium citrnium: An in Vitro Study.Abstract

Document Type : Review Articles

Authors

1 1- Department of Botany Faculty of Women for Arts , Science and Education. Ain Shams Univeristy, Cairo 11757. 2- Egyptian Ministry of Environment , Cairo 11728 , Egypt.

2 Industrial Biotechnology Departement, Genetic Engineering and Biotechnoogy Research Institute, Sadat University ,Egypt

3 Department of Cancer Biology, National Cancer Institute, Cairo University, Cairo, Egypt.

4 women faculty, ain shams universty

5 Botany Department, Faculty of Women for Arts, Science and Education, Ain Shams University, Cairo, Egypt

6 The regional center of the mycology and biotechnology , Al Azhar University

Abstract

In the current study, biogenic selenium nanoparticles (Se-NPs) were extracellularly synthesized by Penicillium citrnium. Se-NPs were structurally and morphologically characterized by using analytical techniques such as: X-ray diffraction (XRD), UV-Vis spectroscopy, Fourier Transform Infrared Spectroscopy (FTIR) and transmission electron microscopy (TEM). Maximum UV absorbance was obtained at 255 nm. and the TEM showed 15–40 nm-sized homogeneous spherical Se-NPs. Anticancer potential of the Se-NPs was evaluated against lung cancer (A-459), hepatocellular carcinoma (HepG2), and its cytotoxicity against normal fibroblast cells (WI-38). The Se-NPs have a significant cytotoxic effect (IC50) of 100.2 ± 3.28 µg/mL against HepG2 cells and IC50 of 142.5 ± 6.91 µg/mL against A-549 cells, whereas it has IC50 of 219.75 ± 10.93 µg/mL against Wl-38 cells. In comparison to the untreated HepG2 cells, the treated cells showed a 1.8 and 1.7-fold increase in superoxide dismutase enzyme (SOD) and glutathione (GSH) content, respectively, with a 0.6 fold drop in catalase (CAT) level. The cell apoptosis rates were also assesed using the Annexin V-FITC staining test. In the treated cells, the rates of necrosis, late apoptosis, and early apoptosis were all markedly elevated. The caspase-3 enzyme level of the treated cells was 2.2 folds higher than that of the untreated cells. Flow cytometer showed an arrest in G2/M phase in comparison to untreated cells after treatment of HepG2 with Se-NP. In conclusion, the biogenic Se-NPs exhibited anticancer activity against HepG2 hepatocellular carcinoma cells through enhanced antioxidant production, apoptosis, and cell cycle arrest pathways.

Keywords

Main Subjects



Articles in Press, Accepted Manuscript
Available Online from 14 May 2024
  • Receive Date: 18 March 2024
  • Revise Date: 06 May 2024
  • Accept Date: 14 May 2024